Avidity Biosciences Inc. (RNA): Price and Financial Metrics
RNA Price/Volume Stats
| Current price | $43.65 | 52-week high | $56.00 |
| Prev. close | $43.25 | 52-week low | $5.68 |
| Day low | $42.21 | Volume | 675,400 |
| Day high | $44.64 | Avg. volume | 1,315,814 |
| 50-day MA | $45.39 | Dividend yield | N/A |
| 200-day MA | $34.85 | Market Cap | 5.21B |
RNA Stock Price Chart Interactive Chart >
Avidity Biosciences Inc. (RNA) Company Bio
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; to design, engineer, and develop therapeutics that combine tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies to access previously undruggable tissue and cell types, and target underlying genetic drivers of diseases. In addition, it develops muscle programs, which focuses on the treatment of muscle atrophy, duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and Pompe diseases. Avidity Biosciences, Inc. was founded in 2012 and is based in La Jolla, California.
RNA Price Returns
| 1-mo | -7.87% |
| 3-mo | 0.30% |
| 6-mo | 59.02% |
| 1-year | 605.17% |
| 3-year | 65.34% |
| 5-year | N/A |
| YTD | 382.32% |
| 2023 | -59.22% |
| 2022 | -6.65% |
| 2021 | -6.86% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...